By 2011, the swine output in China has increased from 2006’s 610 million heads to 660 million heads. Meanwhile, the proportion of scaled swine farming is also expanding gradually. In recent years, the sales value of animal health products in China has been increasing with an annual growth rate of 15-17%. Currently, the sales value of bioproducts for swine is about 1.8-2.0 billion RMB/year, accounting for about 37% of bioproducts sales value and about 7% of animal health products market share (estimated according to “Veterinary Drug Industry Report 2009”).
With the steady expansion of swine farming inventory and scaled farming proportion, swine vaccines (especially commercial vaccines) sales volume will continue to increase in the next 5 years. With the support of our information sites, we conducted research and field investigation on swine immunization situation of over 100 swine farms in northeast China, north China, central China and south China. According to the result of our research and investigation, we summarized and analyzed the adoption situation of vaccines for classical swine fever (CSF), food-and-month disease (FMD), porcine reproductive and respiratory syndrome (PRRS) and Pseudorabies (PR) and finished this report. This report focuses on the following points:
(1) The farms’ attitude towards whether to use these vaccines and whether to change vaccine brands; the adoption rates of each kind of vaccine;
(2) The factors that affect farms’ vaccine purchase; farms’ satisfaction degree towards vaccines of different brands;
(3) The purchase prices, purchase channels and immunization process of farms of different scales and farms in different areas; (4) The current market sizes of these vaccines in farms of different scales and farms in different areas, and the forecast on future market sizes in the next 5 years; (5) The market awareness of the vaccine enterprises; analysis of the current condition, product advantages and marketing situation of key enterprises. We hope our report can be a good reference for you to better understand swine vaccine market in China.